Page last updated: 2024-10-26

dimaprit and Pre-Eclampsia

dimaprit has been researched along with Pre-Eclampsia in 1 studies

Dimaprit: A histamine H2 receptor agonist that is often used to study the activity of histamine and its receptors.

Pre-Eclampsia: A complication of PREGNANCY, characterized by a complex of symptoms including maternal HYPERTENSION and PROTEINURIA with or without pathological EDEMA. Symptoms may range between mild and severe. Pre-eclampsia usually occurs after the 20th week of gestation, but may develop before this time in the presence of trophoblastic disease.

Research Excerpts

ExcerptRelevanceReference
"Women with gestational diabetes (GDM) have an increased risk of preeclampsia and postpartum diabetes."1.72Mediators of inflammation resolution and vasoactive eicosanoids in gestational diabetes and preeclampsia. ( Barden, AE; Beilin, LJ; Mori, TA; Phillips, M; Shinde, S, 2022)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Barden, AE1
Shinde, S1
Phillips, M1
Beilin, LJ1
Mori, TA1

Other Studies

1 other study available for dimaprit and Pre-Eclampsia

ArticleYear
Mediators of inflammation resolution and vasoactive eicosanoids in gestational diabetes and preeclampsia.
    Journal of hypertension, 2022, 11-01, Volume: 40, Issue:11

    Topics: Diabetes, Gestational; Dimaprit; Eicosanoids; Female; Glucose; Humans; Inflammation; Inflammation Me

2022